Source:http://linkedlifedata.com/resource/pubmed/id/11753281
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2001-12-25
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0022-2143
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
138
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
356-8
|
pubmed:dateRevised |
2005-11-16
|
pubmed:meshHeading |
pubmed-meshheading:11753281-Anticoagulants,
pubmed-meshheading:11753281-Heparin,
pubmed-meshheading:11753281-Heparin, Low-Molecular-Weight,
pubmed-meshheading:11753281-Humans,
pubmed-meshheading:11753281-Hypertriglyceridemia,
pubmed-meshheading:11753281-Infusions, Intravenous,
pubmed-meshheading:11753281-Thromboembolism
|
pubmed:year |
2001
|
pubmed:articleTitle |
Heparin in hypertriglyceridemia: friend or foe?
|
pubmed:publicationType |
Editorial,
Comment,
Review
|